Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Bailey

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Human Mutation|June 21, 2021
Prevalence and phenotype associations of complement factor I mutations in geographic atrophyAdnan H Khan, Janice Sutton, Angela J Cree, et al.
American Journal of Ophthalmology|January 10, 2021
Quantification of Key Retinal Features in Early and Late Age-Related Macular Degeneration Using Deep LearningBart Liefers, Paul Taylor, Abdulrahman Alsaedi, et al.
The British Journal of Ophthalmology|February 15, 2015
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12Aaron Y Lee, Cecilia S Lee, Thomas Butt, et al.
Ophthalmology Science|February 2, 2024
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical PracticeRobyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, et al.
The British Journal of Ophthalmology|December 15, 2016
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedemaCatherine Egan, Haogang Zhu, Aaron Lee, et al.
American Journal of Ophthalmology|June 3, 2017
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic RetinopathyCecilia S Lee, Aaron Y Lee, Douglas Baughman, et al.
Trials|February 14, 2019
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trialNoemi Lois, Evie Gardner, Norman Waugh, et al.
Ophthalmology|August 16, 2022
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical TrialNoemi Lois, Christina Campbell, Norman Waugh, et al.
Health Technology Assessment (Winchester, England)|December 21, 2022
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCTNoemi Lois, Christina Campbell, Norman Waugh, et al.
The British Journal of Ophthalmology|May 11, 2017
The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedemaAlastair K Denniston, Usha Chakravarthy, Haogang Zhu, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Human Mutation|June 21, 2021
Prevalence and phenotype associations of complement factor I mutations in geographic atrophyAdnan H Khan, Janice Sutton, Angela J Cree, et al.
American Journal of Ophthalmology|January 10, 2021
Quantification of Key Retinal Features in Early and Late Age-Related Macular Degeneration Using Deep LearningBart Liefers, Paul Taylor, Abdulrahman Alsaedi, et al.
The British Journal of Ophthalmology|February 15, 2015
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12Aaron Y Lee, Cecilia S Lee, Thomas Butt, et al.
Ophthalmology Science|February 2, 2024
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical PracticeRobyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, et al.
The British Journal of Ophthalmology|December 15, 2016
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedemaCatherine Egan, Haogang Zhu, Aaron Lee, et al.
American Journal of Ophthalmology|June 3, 2017
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic RetinopathyCecilia S Lee, Aaron Y Lee, Douglas Baughman, et al.
Trials|February 14, 2019
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trialNoemi Lois, Evie Gardner, Norman Waugh, et al.
Ophthalmology|August 16, 2022
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical TrialNoemi Lois, Christina Campbell, Norman Waugh, et al.
Health Technology Assessment (Winchester, England)|December 21, 2022
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCTNoemi Lois, Christina Campbell, Norman Waugh, et al.
The British Journal of Ophthalmology|May 11, 2017
The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedemaAlastair K Denniston, Usha Chakravarthy, Haogang Zhu, et al.
Pageof 10